Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/
Accepted 2026-05-04 15:00:22 ET · period of report 2026-05-01 · accession 0002084386-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 15:00 | 2026-05-01 | KEQU | Campbell John Jette | Dir | A - Grant | $0.00 | +2,013 | 2,703 | +292% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 2,013 | $0.00 | 2,703 | D | — | — | (F1) Shares awarded under the Company's 2023 Omnibus Incentive Plan, representing the equity portion of the reporting person's annual compensation. |